Skip to main content
Clinical Trials/ISRCTN82317088
ISRCTN82317088
Completed
N/A

Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting antibody: A multicentre, open-label, prospective clinical trial with single treatment arm

South Tees Hospitals NHS Foundation Trust (UK)0 sites46 target enrollmentJune 7, 2010

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
South Tees Hospitals NHS Foundation Trust (UK)
Enrollment
46
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 7, 2010
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
South Tees Hospitals NHS Foundation Trust (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Age 18 or older
  • 2\. Established diagnosis of rheumatoid arthritis
  • 3\. Eligible for treatment with rituximab
  • 4\. Written informed consent

Exclusion Criteria

  • 1\. Concurrent bisphosphonate use
  • 2\. Poor previous compliance

Outcomes

Primary Outcomes

Not specified

Similar Trials